AAAAAA

ITA
ENG

Results: << | 801-825 | 826-850 | 851-875 | 876-900 | >>

Table of contents of journal: *Hepatology

Results: 851-875/15678

Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptorin the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin

Authors: West, DA James, NH Cosulich, SC Holden, PR Brindle, R Rolfe, M Roberts, RA

Citation: Da. West et al., Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptorin the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin, HEPATOLOGY, 30(6), 1999, pp. 1417-1424

The canals of Hering and hepatic stem cells in humans

Authors: Theise, ND Saxena, R Portmann, BC Thung, SN Yee, H Chiriboga, L Kumar, A Crawford, JM

Citation: Nd. Theise et al., The canals of Hering and hepatic stem cells in humans, HEPATOLOGY, 30(6), 1999, pp. 1425-1433

Intention-to-treat analysis of surgical treatment for early hepatocellularcarcinoma: Resection versus transplantation

Authors: Llovet, JM Fuster, J Bruix, J

Citation: Jm. Llovet et al., Intention-to-treat analysis of surgical treatment for early hepatocellularcarcinoma: Resection versus transplantation, HEPATOLOGY, 30(6), 1999, pp. 1434-1440

Interleukin-11 reduces T-cell-dependent experimental liver injury in mice

Authors: Bozza, M Bliss, JL Maylor, R Erickson, J Donnelly, L Bouchard, P Dorner, AJ Trepicchio, WL

Citation: M. Bozza et al., Interleukin-11 reduces T-cell-dependent experimental liver injury in mice, HEPATOLOGY, 30(6), 1999, pp. 1441-1447

Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice

Authors: Lentsch, AB Yoshidome, H Kato, A Warner, RL Cheadle, WG Ward, PA Edwards, MJ

Citation: Ab. Lentsch et al., Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice, HEPATOLOGY, 30(6), 1999, pp. 1448-1453

Kupffer cell-independent acute hepatocellular oxidative stress and decreased bile formation in post-cold-ischemic rat liver

Authors: Kumamoto, Y Suematsu, M Shimazu, M Kato, M Sano, T Makino, N Hirano, K Naito, M Wakabayashi, G Ishimura, Y Kitajima, M

Citation: Y. Kumamoto et al., Kupffer cell-independent acute hepatocellular oxidative stress and decreased bile formation in post-cold-ischemic rat liver, HEPATOLOGY, 30(6), 1999, pp. 1454-1463

Prostaglandin E-1 protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice

Authors: Mokuno, Y Takano, M Matsuguchi, T Nishimura, H Washizu, J Naiki, Y Nimura, Y Yoshikai, Y

Citation: Y. Mokuno et al., Prostaglandin E-1 protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice, HEPATOLOGY, 30(6), 1999, pp. 1464-1472

Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: Effect on transcription factors AP-1 and NF-kappaB

Authors: Roman, J Colell, A Blasco, C Caballeria, J Pares, A Rodes, J Fernandez-Checa, C

Citation: J. Roman et al., Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: Effect on transcription factors AP-1 and NF-kappaB, HEPATOLOGY, 30(6), 1999, pp. 1473-1480

Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat

Authors: Peralta, C Prats, N Xaus, C Gelpi, E Rosello-Catafau, J

Citation: C. Peralta et al., Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat, HEPATOLOGY, 30(6), 1999, pp. 1481-1489

The transforming growth factor beta(1)-inducible transcription factor, TIEG1, mediates apoptosis through oxidative stress

Authors: Ribeiro, A Bronk, SF Roberts, PJ Urrutia, R Gores, GJ

Citation: A. Ribeiro et al., The transforming growth factor beta(1)-inducible transcription factor, TIEG1, mediates apoptosis through oxidative stress, HEPATOLOGY, 30(6), 1999, pp. 1490-1497

Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium

Authors: Lakehal, F Wendum, D Barbu, V Becquemont, L Poupon, R Balladur, P Hannoun, L Ballet, F Beaune, PH Housset, C

Citation: F. Lakehal et al., Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium, HEPATOLOGY, 30(6), 1999, pp. 1498-1506

The human multidrug resistance protein 2 gene: Functional characterizationof the 5 '-flanking region and expression in hepatic cells

Authors: Tanaka, T Uchiumi, T Hinoshita, E Inokuchi, A Toh, S Wada, M Takano, H Kohno, K Kuwano, M

Citation: T. Tanaka et al., The human multidrug resistance protein 2 gene: Functional characterizationof the 5 '-flanking region and expression in hepatic cells, HEPATOLOGY, 30(6), 1999, pp. 1507-1512

Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation

Authors: Pessoa, MG Bzowej, N Berenguer, M Phung, Y Kim, M Ferrell, L Hassoba, H Wright, TL

Citation: Mg. Pessoa et al., Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation, HEPATOLOGY, 30(6), 1999, pp. 1513-1520

Authors: Miwa, S Hashikura, Y Mita, A Kubota, T Chisuwa, H Nakazawa, Y Ikegami, T Terada, M Miyagawa, S Kawasaki, S

Citation: S. Miwa et al., Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure, HEPATOLOGY, 30(6), 1999, pp. 1521-1526

Kupffer cell-induced oxidant stress during hepatic ischemia-reperfusion: Does the controversy continue?

Authors: Jaeschke, H

Citation: H. Jaeschke, Kupffer cell-induced oxidant stress during hepatic ischemia-reperfusion: Does the controversy continue?, HEPATOLOGY, 30(6), 1999, pp. 1527-1528

Pain experienced during percutaneous liver biopsy

Authors: Castera, L Negre, I Samii, K Buffet, C

Citation: L. Castera et al., Pain experienced during percutaneous liver biopsy, HEPATOLOGY, 30(6), 1999, pp. 1529-1530

Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients

Authors: Adinolfi, LE Utili, R Ruggiero, G

Citation: Le. Adinolfi et al., Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients, HEPATOLOGY, 30(6), 1999, pp. 1530-1530

Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients - Reply

Authors: Jonsson, JR Hourigan, LF Purdie, D Clouston, A Macdonald, GA Powell, EE

Citation: Jr. Jonsson et al., Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients - Reply, HEPATOLOGY, 30(6), 1999, pp. 1530-1531

C282Y and H63D mutations in the HFE gene are not associated with porphyriacutanea tarda in Bulgaria

Authors: Ivanova, A von Ahsen, N Adjarov, D Krastev, Z Oellerich, M Wieland, E

Citation: A. Ivanova et al., C282Y and H63D mutations in the HFE gene are not associated with porphyriacutanea tarda in Bulgaria, HEPATOLOGY, 30(6), 1999, pp. 1531-1532

Extremely rare association of HFE mutations with porphyria cutanea tarda in Japanese patients

Authors: Furuyama, K Kondo, M Hirata, K Fujita, H Sassa, S

Citation: K. Furuyama et al., Extremely rare association of HFE mutations with porphyria cutanea tarda in Japanese patients, HEPATOLOGY, 30(6), 1999, pp. 1532-1533

Dissection of the multifunctional "receptor-recycling" endocytic compartment of hepatocytes

Authors: Enrich, C Pol, A Calvo, M Pons, M Jackle, S

Citation: C. Enrich et al., Dissection of the multifunctional "receptor-recycling" endocytic compartment of hepatocytes, HEPATOLOGY, 30(5), 1999, pp. 1115-1120

Long-term results of patients undergoing liver transplantation for primarysclerosing cholangitis

Authors: Graziadei, IW Wiesner, RH Marotta, PJ Porayko, MK Hay, JE Charlton, MR Poterucha, JJ Rosen, CB Gores, GY LaRusso, NF Krom, RAF

Citation: Iw. Graziadei et al., Long-term results of patients undergoing liver transplantation for primarysclerosing cholangitis, HEPATOLOGY, 30(5), 1999, pp. 1121-1127

Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line

Authors: Park, J Tadlock, L Gores, GJ Patel, T

Citation: J. Park et al., Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line, HEPATOLOGY, 30(5), 1999, pp. 1128-1133

Randomized clinical trials in HEPATOLOGY: Predictors of quality

Authors: Kjaergard, LL Nikolova, D Gluud, C

Citation: Ll. Kjaergard et al., Randomized clinical trials in HEPATOLOGY: Predictors of quality, HEPATOLOGY, 30(5), 1999, pp. 1134-1138

Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices

Authors: Barange, K Peron, JM Imani, K Otal, P Payen, JL Rousseau, H Pascal, JP Joffre, F Vinel, JP

Citation: K. Barange et al., Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices, HEPATOLOGY, 30(5), 1999, pp. 1139-1143

Risultati: << | 801-825 | 826-850 | 851-875 | 876-900 | >>